Yolande E. Knight

1.9k total citations
22 papers, 1.5k citations indexed

About

Yolande E. Knight is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Yolande E. Knight has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 13 papers in Pathology and Forensic Medicine and 8 papers in Physiology. Recurrent topics in Yolande E. Knight's work include Migraine and Headache Studies (19 papers), Trigeminal Neuralgia and Treatments (12 papers) and Neuroscience of respiration and sleep (6 papers). Yolande E. Knight is often cited by papers focused on Migraine and Headache Studies (19 papers), Trigeminal Neuralgia and Treatments (12 papers) and Neuroscience of respiration and sleep (6 papers). Yolande E. Knight collaborates with scholars based in United Kingdom, Sweden and United States. Yolande E. Knight's co-authors include Peter J. Goadsby, Thorsten Bartsch, Miles Levy, Karen L. Hoskin, J.D. Classey, Holger Kaube, Michele P. Lasalandra, Simon Akerman, Lars Edvinsson and Paul Butler and has published in prestigious journals such as Journal of Neuroscience, Annals of Neurology and Brain Research.

In The Last Decade

Yolande E. Knight

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yolande E. Knight United Kingdom 17 1.3k 874 714 277 162 22 1.5k
Margarida Martins-Oliveira United States 6 1.2k 1.0× 559 0.6× 408 0.6× 238 0.9× 124 0.8× 8 1.4k
Karen L. Hoskin Australia 22 1.8k 1.4× 1.3k 1.4× 1.0k 1.4× 313 1.1× 72 0.4× 28 2.1k
Vibeke Ulrich Denmark 14 1.2k 1.0× 532 0.6× 460 0.6× 346 1.2× 58 0.4× 15 1.3k
Sheena K. Aurora United States 25 1.7k 1.3× 946 1.1× 761 1.1× 137 0.5× 106 0.7× 48 1.9k
Samaira Younis Denmark 19 1.1k 0.9× 554 0.6× 338 0.5× 183 0.7× 112 0.7× 32 1.3k
MA Moskowitz United States 6 850 0.7× 498 0.6× 340 0.5× 187 0.7× 47 0.3× 7 1.1k
Agustin Melo‐Carrillo United States 18 1.2k 0.9× 618 0.7× 449 0.6× 293 1.1× 60 0.4× 32 1.5k
Nazia Karsan United Kingdom 19 846 0.7× 420 0.5× 315 0.4× 148 0.5× 82 0.5× 50 992
Stephane Pollentier Germany 6 904 0.7× 518 0.6× 364 0.5× 145 0.5× 62 0.4× 9 1.1k
Mohammad Al‐Mahdi Al‐Karagholi Denmark 21 1.2k 1.0× 571 0.7× 412 0.6× 249 0.9× 58 0.4× 60 1.5k

Countries citing papers authored by Yolande E. Knight

Since Specialization
Citations

This map shows the geographic impact of Yolande E. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolande E. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolande E. Knight more than expected).

Fields of papers citing papers by Yolande E. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolande E. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolande E. Knight. The network helps show where Yolande E. Knight may publish in the future.

Co-authorship network of co-authors of Yolande E. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Yolande E. Knight. A scholar is included among the top collaborators of Yolande E. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolande E. Knight. Yolande E. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitsikostas, Dimos D., Yolande E. Knight, Michele P. Lasalandra, Nikolaos Kavantzas, & Peter J. Goadsby. (2011). Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization?. The Journal of Headache and Pain. 12(4). 411–417. 19 indexed citations
2.
Knight, Yolande E., et al.. (2009). A life-threatening complication of Ehlers–Danlos syndrome. British Journal of Hospital Medicine. 70(6). 360–360. 2 indexed citations
3.
Doaré, Kirsty Le, Simon Akerman, Philip R. Holland, et al.. (2006). Occipital afferent activation of second order neurons in the trigeminocervical complex in rat. Neuroscience Letters. 403(1-2). 73–77. 60 indexed citations
5.
Knight, Yolande E., J.D. Classey, Michele P. Lasalandra, et al.. (2005). Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Brain Research. 1045(1-2). 1–11. 58 indexed citations
6.
Bartsch, Thorsten, Miles Levy, Yolande E. Knight, & Peter J. Goadsby. (2005). Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus. Pain. 117(1). 30–39. 56 indexed citations
7.
Bartsch, Thorsten, Yolande E. Knight, & Peter J. Goadsby. (2004). Activation of 5‐HT1B/1D receptor in the periaqueductal gray inhibits nociception. Annals of Neurology. 56(3). 371–381. 149 indexed citations
8.
Benjamin, Laura, Miles Levy, Michele P. Lasalandra, et al.. (2004). Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiology of Disease. 16(3). 500–505. 85 indexed citations
9.
Bartsch, Thorsten, Miles Levy, Yolande E. Knight, & Peter J. Goadsby. (2004). Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain. 109(3). 367–378. 219 indexed citations
10.
Levy, Miles, Yolande E. Knight, C.T. O'Shaughnessy, & Peter J. Goadsby. (2003). Effect of IL-1β microinjection into the posterior hypothalamic area on trigeminal nociception in the rat. Journal of Neural Transmission. 110(12). 1349–1358. 1 indexed citations
11.
Bruun, Anitha, et al.. (2003). Immunoreactivity of NOS, CGRP,PACAP, SP and VIP in the trigeminal nucleus caudalis and in thecervical spinal cord C1 and C2 of the cat. The Journal of Headache and Pain. 4(3). 156–163. 12 indexed citations
12.
Knight, Yolande E., Thorsten Bartsch, & Peter J. Goadsby. (2002). Trigeminal antinociception induced by bicuculline in the periaqueductal gray (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neuroscience Letters. 336(2). 113–116. 42 indexed citations
13.
Knight, Yolande E. & Peter J. Goadsby. (2001). The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?. Neuroscience. 106(4). 793–800. 194 indexed citations
14.
Knight, Yolande E., Lars Edvinsson, & Peter J. Goadsby. (2001). 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT1B/1D receptor agonist activity?. Neuropharmacology. 40(4). 520–525. 27 indexed citations
15.
Classey, J.D., Yolande E. Knight, & Peter J. Goadsby. (2001). The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Research. 907(1-2). 117–124. 52 indexed citations
16.
Knight, Yolande E., Lars Edvinsson, & Peter J. Goadsby. (1999). Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Neuropeptides. 33(1). 41–46. 47 indexed citations
18.
Goadsby, Peter J., Yolande E. Knight, & Karen L. Hoskin. (1997). Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 73(1). 23–28. 119 indexed citations
19.
Goadsby, Peter J. & Yolande E. Knight. (1997). Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5‐hydroxy‐tryptamine (5‐HT1B/1D) receptors. British Journal of Pharmacology. 122(5). 918–922. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026